IL-17+ cells comprised around 2–3% of the CD3 T cell infiltrate in liver disease, as defined by frequencies generated by immunohistochemical analysis (Fig. 1G) and by calculating the frequencies of CD3+ IL-17 secreting cells, in cells freshly isolated from liver tissue by flow cytometry (Fig. 1H). This evidence concerns the gene IL17A and liver disorder.